Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip F Hughes

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Combinatorial Chemistry|May 11, 2004
Array reactors for parallel synthesisPhilip F Hughes, Thomas H Graham, Jose S Mendoza
The Journal of Organic Chemistry|July 12, 1996
Total Synthesis of (-)- and (+)-Balanol(1)John W. Lampe, Philip F. Hughes, Christopher K. Biggers, et al.
Antiviral Research|April 9, 2016
An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral targetMatthew K Howe, Brittany L Speer, Philip F Hughes, et al.
The Journal of Biological Chemistry|January 9, 2020
A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinaseScott A Scarneo, Philip F Hughes, Kelly W Yang, et al.
Journal of Medicinal Chemistry|May 30, 2003
Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferaseShinji Nara, Rieko Tanaka, Jun Eishima, et al.
Science Translational Medicine|December 17, 2020
Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1Bushu Dong, Alex M Jaeger, Philip F Hughes, et al.
Bioorganic & Medicinal Chemistry|April 24, 2012
A highly selective Hsp90 affinity chromatography resin with a cleavable linkerPhilip F Hughes, Jared J Barrott, David A Carlson, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2018
Identification of Hsp90 Inhibitors with Anti-Plasmodium ActivityDora Posfai, Amber L Eubanks, Allison I Keim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2017
<i>In Vivo</i> Detection of HSP90 Identifies Breast Cancers with Aggressive BehaviorTakuya Osada, Kensuke Kaneko, William R Gwin, et al.
Cell Death & Disease|April 17, 2024
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancersHelene Damhofer, Tülin Tatar, Benjamin Southgate, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Combinatorial Chemistry|May 11, 2004
Array reactors for parallel synthesisPhilip F Hughes, Thomas H Graham, Jose S Mendoza
The Journal of Organic Chemistry|July 12, 1996
Total Synthesis of (-)- and (+)-Balanol(1)John W. Lampe, Philip F. Hughes, Christopher K. Biggers, et al.
Antiviral Research|April 9, 2016
An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral targetMatthew K Howe, Brittany L Speer, Philip F Hughes, et al.
The Journal of Biological Chemistry|January 9, 2020
A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinaseScott A Scarneo, Philip F Hughes, Kelly W Yang, et al.
Journal of Medicinal Chemistry|May 30, 2003
Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferaseShinji Nara, Rieko Tanaka, Jun Eishima, et al.
Science Translational Medicine|December 17, 2020
Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1Bushu Dong, Alex M Jaeger, Philip F Hughes, et al.
Bioorganic & Medicinal Chemistry|April 24, 2012
A highly selective Hsp90 affinity chromatography resin with a cleavable linkerPhilip F Hughes, Jared J Barrott, David A Carlson, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2018
Identification of Hsp90 Inhibitors with Anti-Plasmodium ActivityDora Posfai, Amber L Eubanks, Allison I Keim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2017
<i>In Vivo</i> Detection of HSP90 Identifies Breast Cancers with Aggressive BehaviorTakuya Osada, Kensuke Kaneko, William R Gwin, et al.
Cell Death & Disease|April 17, 2024
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancersHelene Damhofer, Tülin Tatar, Benjamin Southgate, et al.
Pageof 3